– CANADA, Toronto – Allied Properties Real Estate Investment Trust (TSX: AP.UN) today announced the appointment of Hazel Claxton to its Board as a trustee.
“Hazel Claxton is a most welcome addition to our Board as we continue the process of board renewa. She brings to Allied a unique combination of commercial acumen and a strategic focus on talent, and I know she will make a significant contribution to Allied in the years aheadl,” said Board Chair, Gordon Cunningham.
About Hazel Claxton
Hazel Claxton is a corporate director. She served as EVP and CHRO with Morneau Shepell Inc. from 2013 to 2018. Prior to that, Ms. Claxton spent 29 years at PwC Canada, where she held several leadership roles, including Canadian Leadership Group member, Human Capital leader, and Partner within the Corporate Advisory and Restructuring Group, an area she practiced in for 20 years.
Ms. Claxton currently serves on the boards of TELUS Corporation, the University Pension Plan Ontario and Unity Health Toronto. Previously, she served on the boards of Queen’s University, St. Michael’s Hospital and the Shaw Festival Theatre. Hazel holds a Bachelor of Commerce from Queen’s University and the ICD.D designation from the Institute of Corporate Directors. She is a Chartered Professional Accountant and Chartered Accountant.
About ALLIED
Allied is a leading operator of distinctive urban workspace in Canada’s major cities and network-dense UDC space in Toronto. Allied’s mission is to provide knowledge-based organizations with workspace and UDC space that is sustainable and conducive to human wellness, creativity, connectivity and diversity. Allied’s vision is to make a continuous contribution to cities and culture that elevates and inspires the humanity in all people.
For more information : https://www.alliedreit.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
